Liquidia Corporation (LQDA) Financials
LQDA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 120.4 million | 73.1 million |
2023-09-30 | 111.6 million | 63.6 million |
2023-06-30 | 121.6 million | 60.9 million |
2023-03-31 | 128.9 million | 47.3 million |
LQDA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -16.2 million | 2.6 million |
2023-09-30 | -22.0 million | 2.5 million |
2023-06-30 | -5.8 million | 2.5 million |
2023-03-31 | -8.8 million | 2.6 million |
LQDA Net Income
No data available :(
LQDA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 83.7 million | - | 3.5 million |
2023-09-30 | 76.2 million | - | 3.8 million |
2023-06-30 | 88.2 million | - | 4.0 million |
2023-03-31 | 94.4 million | - | 4.3 million |
LQDA Shares Outstanding
LQDA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 206000 | 12.6 million | 17.1 million | - |
2023-09-30 | 10.5 million | 7.4 million | 10.6 million | - |
2023-06-30 | 243000 | 17.7 million | 9.2 million | - |
2023-03-31 | 366000 | 5.3 million | 7.8 million | - |
LQDA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.5 million | 1.3 million |
2023-09-30 | 3.7 million | 570000 |
2023-06-30 | 4.8 million | 671000 |
2023-03-31 | 4.5 million | 654000 |
LQDA
Price: $12.98
52 week price:
Earnings Per Share: -1.21 USD
P/E Ratio: -16.82
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 65756
Market Capitalization: 1.0 billion